ArticleMarine biotechnology (New York, N.Y.)2026
Construction of an Enhanced Phage Display Library of Artificially Randomized vNARs from Cloudy Catshark (Scyliorhinus Torazame) and Screening against Miamiensis Avidus.
Article in Marine biotechnology (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Single-domain antibodies (sdAbs), particularly variable new antigen receptors (vNARs) from cartilaginous fish, represent promising tools for therapeutic and diagnostic applications due to their small size, high stability, and binding versatility. In this study, we developed a semi-synthetic, open reading frame (ORF)-enriched vNAR library from the cloudy catshark (Scyliorhinus torazame) and optimized it for efficient expression in Escherichia coli through codon optimization. To improve the precision of selection, a β-lactamase-based ORF filtering system and a trypsin-sensitive helper phage packaging system were incorporated to minimize non-functional clones and helper phage contamination. The resulting vNAR library exhibited high diversity and functionality, as demonstrated by successful biopanning against both model (hen egg white lysozyme) and pathogenic (Miamiensis avidus) targets. Screening against M. avidus resulted in the isolation of vNAR-displaying phage clones with robust and specific surface-binding activity, as validated by ELISA and live-cell binding assays. These results highlight the utility of synthetic vNAR libraries in developing specific molecular binders and suggest their potential application in controlling scuticociliatosis in aquaculture.
Indexed as
Identifiers
41721894What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.